Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ascendis Pharma Ads (NQ: ASND )

132.90 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 7, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 86,437
Open 134.68
Bid (Size) 132.84 (1)
Ask (Size) 133.22 (7)
Prev. Close 132.90
Today's Range 131.28 - 136.77
52wk Range 119.11 - 183.98
Shares Outstanding 53,750,386
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Ascendis Pharma A/S Announces Presentations for TransCon™ PTH at Upcoming Medical Conferences
From GlobeNewswire News Releases
Ascendis Pharma A/S Announces Participation at the BofA Securities 2021 Virtual Health Care Conference
From GlobeNewswire News Releases

Performance

YTD
-19.69%
-19.69%
1 Month
+5.80%
+5.80%
3 Month
-13.66%
-13.66%
6 Month
-21.07%
-21.07%
1 Year
-7.05%
-7.05%

More News

Read More
Ascendis Pharma A/S Announces Presentations for TransCon™ hGH at Upcoming Medical Conferences
From GlobeNewswire News Releases
Ascendis Pharma A/S Announces Participation at the J.P. Morgan 10th Annual Napa Valley Biotech Forum
From GlobeNewswire News Releases
Ascendis Pharma A/S Presents 6-Month Open-Label Extension Data from Phase 2 PaTH Forward Trial of TransCon PTH in Adult Hypoparathyroidism at ENDO 2021
From GlobeNewswire News Releases
Ascendis Pharma A/S Announces Participation at Oppenheimer 31st Annual Healthcare Conference
From GlobeNewswire News Releases
Ascendis Pharma A/S Reports Full Year 2020 Financial Results
From GlobeNewswire News Releases
Ascendis Pharma A/S Announces Seven Presentations at ENDO 2021, Demonstrating Commitment to People with Rare Endocrine Diseases
From GlobeNewswire News Releases
Ascendis Pharma A/S Announces Full Year 2020 Financial Results and Business Update Conference Call on March 10
From GlobeNewswire News Releases
Ascendis Pharma A/S Announces New “Outgrow GHD” Educational Resource to Support Rare Disease Day 2021
From GlobeNewswire News Releases
Ascendis Pharma A/S Announces Participation at SVB Leerink 10th Annual Global Healthcare Conference
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.